OTC · Medical - Diagnostics & Research

Medivolve Inc. (MEDVF) Stock

$0.00 OTC: MEDVF Healthcare

Medivolve Inc. is a primary investment firm headquartered in Toronto, Canada.

Valuation

MetricValue
Price$0.00
Market Cap$2702
P/E Ratio-0.21
P/B Ratio-0.05
P/S Ratio0.00
EPS (TTM)$-0.61
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE100.00%
ROA-800.00%
ROCE22.57%
Gross Margin-300.00%
Operating Margin-400.00%
Net Margin-1600.00%
Debt/Equity-0.12
Current Ratio0.06

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$11.0M$87.0M$1.0M$1.0M
Operating Profit$-3.0M$-24.0M$0$-14.0M$-4.0M
Net Profit$-3.0M$-38.0M$-7.0M$-18.0M$-16.0M
EPS$-1.19$-5.66$-0.34$-0.68$-0.61
Op Margin1694.7%-230.8%-0.1%-1044.1%-521.5%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$2.0M$19.0M$59.0M$19.0M$2.0M
Total Liabilities$0$29.0M$41.0M$18.0M$18.0M
Cash$0$1.0M$0$4.0M$1.0M
Borrowings$0$20.0M$2.0M$2.0M$2.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-4.0M$-11.0M$-9.0M$6.0M$-3.0M
Investing Cash Flow$-1.0M$-9.0M$-1.0M$0$0
Financing Cash Flow$0$0$0$-1.0M$-1.0M
Net Cash Flow$-4.0M$1.0M$-1.0M$4.0M$-3.0M
Free Cash Flow$-4.0M$-15.0M$-9.0M$6.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.61
FCF Yield-386.51%
Quick Ratio0.08
Interest Coverage0.00
Return 1Y-95.00%
Return 3Y-99.72%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIOIFBiome Grow Inc. $0.00 — -0.01 $56208 0.00%
CBGLCannabis Global Inc. $0.00 — -3.40 $56821 0.00%
CEOSCeCors, Inc. $0.01 -14.08% 0.67 $1.91M 0.00%
IMMBImmunotech Laboratories, Inc. $0.00 — -0.22 $114993 0.00%
INSDInstadose Pharma Corp. $0.00 — -0.02 $53193 0.00%

About Medivolve Inc.

Medivolve Inc. is a primary investment firm headquartered in Toronto, Canada. Established in 2005, this company, formerly known as QuestCap Inc., channels its investments predominantly into healthcare technology, industrial enterprises, and information technology.

Medivolve Inc. (MEDVF) stock trades at $0.00 with a market capitalization of $2702. The stock is valued at a price-to-earnings (P/E) ratio of -0.21, price-to-book of -0.05, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Medivolve Inc. generates a return on equity (ROE) of 100.00% — well above the market average, a sign of a high-quality business, return on capital employed of 22.57%, an operating margin of -400.00%, a net profit margin of -1600.00%.

Official website: www.medivolve.ca

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides